From scientific discoveries to promising clinical trials, City of Hope constantly advances new and better ways to improve the lives of people here and throughout the world.
You can find the latest information on our research, clinical and educational programs through this listing of current press releases.
Linda Malkas, Ph.D., deputy director of basic research for City of Hope who holds the M.T. & B.A. Ahmadinia Professorship in Molecular Oncology, has been appointed to the governing board of the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency.
City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, today announced three new members to its board of directors: Barbara Bruser, senior managing director with First Republic Private Wealth Management, Steven B. Fink, former chief executive officer of Lawrence Investments LLC, and William J. Post, chairman of the board of Translational Genomics Research Institute (TGen).
The stories of patients who have benefited from stem cell therapies funded by the California Institute for Regenerative Medicine (CIRM) will be highlighted at the second symposium of the institute’s Alpha Stem Cell Clinics Network on Thursday, March 23, at City of Hope.
Some type 1 diabetes (T1D) patients can be cured from the disease, at least for a number of years, with a stem cell transplant – those were the results of a clinical trial monitored by City of Hope’s Bart Roep, Ph.D., the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes and professor/founding chair, Department of Diabetes Immunology. The results were published recently in the journal, Frontiers in Immunology.
Often, years can pass between the time a breast cancer patient successfully goes into remission and a related brain tumor develops. During that time, the breast cancer cells somehow hide, escaping detection as they grow and develop. Now City of Hope researchers have found out how.
An international team of researchers led by City of Hope’s Bart Roep, Ph.D., the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes and professor/founding chair of the Department of Diabetes Immunology, has been able to justify an alternative theory about the cause of type 1 diabetes (T1D) through experimental work. The study results were published online today in the journal Nature Medicine.
An international team of researchers led by City of Hope’s Markus Müschen, M.D., Ph.D., the Norman and Sadie Lee Foundation Endowed Professor in Pediatrics and founding chair of the Department of Systems Biology, found a connection between drug-resistance in acute lymphoblastic leukemia (ALL) and increased sugar uptake in the ALL cells, according to the paper titled, “Metabolic gatekeeper function of B-lymphoid transcription factors,” published today in Nature.
World-renowned diabetes researcher Arthur D. Riggs, Ph.D., director of the Diabetes & Metabolism Research Institute of City of Hope and director emeritus of Beckman Research Institute of City of Hope, has been named the Samuel Rahbar Chair in Diabetes & Drug Discovery, which honors the life and legacy of the late renowned scientist.
A significant philanthropic gift from the Campbell family of Las Vegas, NV, will establish a new endowed chair to honor City of Hope’s former Chief Medical Officer Alexandra M. Levine, M.D., M.A.C.P.
City of Hope, a world-renowned independent research and cancer and diabetes treatment center, and San Antonio Regional Hospital announced today an affiliation agreement that will significantly expand access to leading-edge, high-quality cancer care, research and services in the Inland Empire.